publicações selecionadas artigo académico The potential of the fibronectin inhibitor RGDS in the development of therapies for glioblastoma. Biomolecules. 2024 documento Treatment of glioblastoma with a hydrogel to sustain the release of chemotherapeutic agents 2019
